Go Pro

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:THRD

Third Harmonic Bio (THRD) Stock Price, News & Analysis

Third Harmonic Bio logo

About Third Harmonic Bio Stock (NASDAQ:THRD)

Key Stats

Today's Range
$5.38
$5.38
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
247,013 shs
Market Capitalization
$242.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

TF Financial Corporation is a savings and loan holding company. The Company's direct and indirect subsidiaries include Third Federal Bank (the Bank), Teragon Financial Corporation, Penns Trail Development Corporation and Third Delaware Corporation. The Bank is a community oriented Pennsylvania stock savings bank offering a variety of financial services to meet the needs of the communities it serves. As of December 31, 2011 the Bank operated fourteen branch offices in Bucks and Philadelphia Counties, Pennsylvania and in Mercer County, New Jersey. During the year ended December 31, 2011, the Company's subsidiary, TF Investments Corporation merged into TF Financial Corporation. In July 2013, the Company acquired Roebling Financial Corp, Inc. (Roebling) and its wholly-owned subsidiary, Roebling Bank.

Receive THRD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Third Harmonic Bio and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

THRD Stock News Headlines

THRD Share News Today
Third Harmonic Bio to Delist from Nasdaq
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.tc pixel
See More Headlines

THRD Stock Analysis - Frequently Asked Questions

Third Harmonic Bio, Inc. (NASDAQ:THRD) released its earnings results on Thursday, May, 8th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.26) by $0.09.

Third Harmonic Bio (THRD) raised $185 million in an initial public offering (IPO) on Wednesday, September 14th 2022. The company issued 10,900,000 shares at $16.00-$18.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that Third Harmonic Bio investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Adobe (ADBE), ServiceNow (NOW) and e.l.f. Beauty (ELF).

Company Calendar

Last Earnings
5/08/2025
Today
9/05/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:THRD
CIK
921051
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.62)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$45.47 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-19.27%
Return on Assets
-18.67%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
54.10
Quick Ratio
54.10

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.33 per share
Price / Book
0.85

Miscellaneous

Outstanding Shares
45,130,000
Free Float
41,608,000
Market Cap
$242.80 million
Optionable
No Data
Beta
2.12
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NASDAQ:THRD) was last updated on 9/6/2026 by MarketBeat.com Staff.
From Our Partners